Fluo Labs: The Future of Allergy Relief (212)

Episode 12 • May 14, 2022 • 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 16

August 04, 2021 • 00:35:31
Episode Cover

Featured Family Office: Nottingham Spirk / Katherine Hill Ritchie (016)

Katherine Hill Ritchie has extensive background running single family offices including a strong emphasis on sourcing alternative investments. Her most recent role involves both...

Listen

Episode 5

February 09, 2022 • 00:43:54
Episode Cover

Jaffar Raza, MD - Opportunities, Cost Management and Technology (205)

Jaffar Raza, MD is a board certified Interventional Cardiologist affiliated with Lenox Hill, Hackensack and Holy name hospitals. He completed his residency in Internal...

Listen

Episode 7

July 09, 2021 • 00:19:12
Episode Cover

Andrew Malloy on Family Office Impact Investing (007)

Andrew Malloy spent a career on Wall Street and also happens to be part of a 3rd generation family office created because of his...

Listen